drugset / Trial / NCT00565916

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

NCT00565916

RandomizedParallel-groupDouble-blindTreatment

Summary

Estrogen and progesterone are two main female sex hormones. When a woman goes through menopause, the body's production of estrogen and progesterone significantly decreases. Recent studies have shown that the breakdown of fatty acids in cardiac muscle is important in maintaining a healthy heart, and that estrogen may enhance this process. Also, cardiovascular disease (CVD) occurs more frequently in postmenopausal women than in premenopausal women. This study will determine in postmenopausal women whether estrogen increases the heart's ability to use fats as energy and whether progesterone decreases this effect.

Timeline

Start
2004-08
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg Oral
Subject conjugated estrogens Other / unclassified 0.3 mg Topical

Indications

No indication recorded.